Libbs Ventures

Libbs is a leading Brazilian pharmaceutical company that has established a significant presence in the biotechnology and specialty medicine sectors. Through its Libbs Ventures arm, the company actively invests in and partners with innovative startups to drive advancements in digital health, drug delivery, and diagnostic technologies. Libbs is a pioneer in the domestic production of biosimilar monoclonal antibodies, operating a sophisticated manufacturing complex in Embu das Artes that utilizes advanced single-use technology. The company's extensive portfolio covers critical therapeutic areas such as oncology, gynecology, cardiovascular health, and neuropsychiatry. Libbs remains a privately held, 100% Brazilian-owned entity committed to expanding access to high-quality healthcare solutions across Latin America.